FlowPhysix was founded with the vision to set new standards for the treatment of endovascular diseases. The company’s first area of focus is peripheral thrombectomy – where significant performance gaps exist with current thrombectomy systems and physicians continue to seek better solutions for treating their patients. By leveraging the foundational science of fluid flow and through extensive studies of clot morphology and blood flow, the company has developed the FLOWRUNNER™ Aspiration System. This breakthrough system has proven to deliver significant performance advantages over conventional aspiration and stentriever thrombectomy systems.